Sensing Bad: Are Co-stimulatory CAR-Expressing γδ T Cells Safer?

被引:2
|
作者
Parihar, Robin [1 ]
机构
[1] Texas Childrens Hosp, Baylor Coll Med, Ctr Cell & Gene Therapy, Hematol Oncol Sect, 1102 Bates Ave,Suite 1770-02, Houston, TX 77030 USA
关键词
CANCER-IMMUNOTHERAPY; RECEPTOR; RECOGNITION; IMMUNITY;
D O I
10.1016/j.ymthe.2017.04.012
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页码:1064 / 1066
页数:4
相关论文
共 50 条
  • [1] Co-Stimulatory Receptor Signaling in CAR-T Cells
    Honikel, Mackenzie M.
    Olejniczak, Scott H.
    BIOMOLECULES, 2022, 12 (09)
  • [2] The Implementation of TNFRSF Co-Stimulatory Domains in CAR-T Cells for Optimal Functional Activity
    He, Yuan
    Vlaming, Martijn
    van Meerten, Tom
    Bremer, Edwin
    CANCERS, 2022, 14 (02)
  • [3] Influence of CAR co-stimulatory domains on downstream signaling and CAR-T cell exhaustion
    Kouro, Taku
    Mano, Yasunobu
    Kasajima, Rika
    Hoshino, Daisuke
    Tsuji, Shoutaro
    Imai, Kohzoh
    Sasada, Tetsuro
    CANCER SCIENCE, 2025, 116 : 513 - 513
  • [4] Advantages and applications of CAR-expressing natural killer cells
    Glienke, Wolfgang
    Esser, Ruth
    Priesner, Christoph
    Suerth, Julia D.
    Schambach, Axel
    Wels, Winfried S.
    Grez, Manuel
    Kloess, Stephan
    Arseniev, Lubomir
    Koehl, Ulrike
    FRONTIERS IN PHARMACOLOGY, 2015, 6
  • [5] Co-Stimulatory Signaling Boosts CAR T Cell Efficacy Against CLL
    Zhao, Ziran
    Collins, McKensie
    Sun, Clare
    Wiestner, Adrian
    Melenhorst, J. Joseph
    BLOOD, 2022, 140 : 10255 - 10256
  • [6] CAR-Expressing Natural Killer Cells for Cancer Retargeting
    Kloess, Stephan
    Kretschmer, Anna
    Stahl, Lilly
    Fricke, Stephan
    Koehl, Ulrike
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2019, 46 (01) : 4 - 13
  • [7] Co-stimulatory requirements of effector T cells at inflammatory sites
    Xu, M
    Lepisto, AJ
    Hendricks, RL
    DNA AND CELL BIOLOGY, 2002, 21 (5-6) : 461 - 465
  • [8] The Effects of Co-Stimulatory Endodomains on the Fate of T Cells Expressing a Tumor Directed Chimeric Antigen Receptor (CAR) In Human Subjects with B Cell Malignancies
    Savoldo, Barbara
    Ramos, Carlos A.
    Bollard, Catherine M.
    Liu, Enli
    Mims, Martha
    Keating, Michael
    Gee, Adrian P.
    Mei, Zhuyong
    Robney, Cliona M.
    Heslop, Helen E.
    Brenner, Malcolm K.
    Dotti, Gianpietro
    BLOOD, 2010, 116 (21) : 1610 - 1611
  • [9] T cell co-stimulatory factors
    Greisen, Stinne
    Kunder, Rebecca
    Deleuran, Bent
    RHEUMATOLOGY, 2017, 56 (06) : 861 - 862
  • [10] CAR-expressing NK cells for cancer therapy: a new hope
    Xia , Jufeng
    Minamino, Shuichi
    Kuwabara, Kazuma
    BIOSCIENCE TRENDS, 2020, 14 (05) : 354 - 359